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INTRODUCTION
Relative pupillary block (PB) is considered to be the primary me -
chanism for angle closure(1-3). Although laser peripheral iridotomy 
(LPI) remains the cornerstone of angle-closure management, it does 
not widen the angle in all cases, as approximately 20%-30% of these 
patients continue to exhibit appositional angle closure in the pre-
sence of a patent iridotomy(1-3). In these cases, non-PB mechanisms, 
such as lens-induced, plateau iris, and peripheral angle crowding, 
may be involved(4-7). Argon laser peripheral iridoplasty (ALPI) and lens 
extraction have been proposed as effective procedures to manage 
eyes with persistent occludable angles(8-10).
While dealing with cases of primary angle closure (with or without 
glaucoma), identification of the underlying mechanism is of the utmost 
importance because each may follow a different course and require a 
different treatment approach. Although there is extensive informa-
tion in the literature regarding the main etiologies and guidelines 
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AbsTRACT
Purpose: To assess the prevalence and treatment outcomes of angle-closure 
mechanisms other than pupillary block in a population of Brazilian patients. 
Methods: A retrospective chart review was conducted to evaluate patients who 
had undergone laser peripheral iridotomy (LPI) due to occludable angles at a single 
institution between July 2009 and April 2012. An occludable angle was defined as 
an eye in which the posterior trabecular meshwork was not visible for ≥180° on 
dark-room gonioscopy. Key exclusion criteria were any form of secondary glaucoma 
and the presence of >90° of peripheral anterior synechiae. Collected data were 
age, race, gender, angle-closure mechanism (based on indentation goniocopy and 
ultrasound biomicroscopy), intraocular pressure (IOP), number of antiglaucoma 
medications and subsequent management during follow-up. If both eyes were 
eligible, the right eye was arbitrarily selected for analysis. 
Results: A total of 196 eyes of 196 consecutive patients (mean age 58.3 ± 11.6 
years) who underwent LPI were included. In most of the patients [86% (169 pa-
tients; 133 women and 36 men]), LPI sucessfully opened the angle. Mean IOP was 
reduced from 18.3 ± 6.4 mmHg to 15.4 ± 4.5 mmHg after LPI (p<0.01). Among 
the 27 patients with persistent occludable angles, the most common underlying 
mechanisms were plateau iris (56%) and lens-induced component (34%). Most of 
these patients (85%) were treated with argon laser peripheral iridoplasty (ALPI); 
approximately 90% showed non-occludable angles following the laser procedure 
(mean IOP reduction of 18.9%), with no significant differences between patients 
with plateau iris and lens-induced components (p=0.34; mean follow-up of 11.4 
± 3.6 months). 
Conclusions: Our findings suggest that, in this population of Brazilian patients, 
several eyes with angle closure were not completely treated with LPI. In the pre-
sent large case series involving middle-age patients, plateau iris was the leading 
cause of persistent angle closure and was effectively treated with ALPI. A detailed 
eye examination with indentation gonioscopy should always be performed after 
LPI to rule out persistent angle closure due to non-pupillary block mechanisms.
Keywords: Angle closure; Non-pupillary block mechanisms; Iris diseases; Iris/
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RESUMO
Objetivo: Reportar a prevalência e os resultados terapêuticos em casos de fechamento 
angular por outros mecanismos além de bloqueio pupilar em uma população de 
pacientes brasileiros. 
Método: Realizou-se um estudo retrospectivo para avaliar pacientes apresentando 
ângulo oclusível submetidos à iridotomia periférica a laser (LPI), em uma única insti-
tuição, entre julho/2009 e abril/2012. Ângulo oclusível foi definido pela não observação 
do trabeculado posterior em mais de 180° à gonioscopia sem identação. Olhos com 
glaucomas secundários ou >90º de sinéquia anterior periférica foram excluídos. Fo ram 
coletados os seguintes dados: idade, raça, sexo, mecanismo de fechamento angu-
lar (com base na gonioscopia e biomicroscopia ultrassônica), pressão intraocular 
(PIO), número de medicações antiglaucomatosas e manejo subsequente durante o 
seguimento. Sempre que ambos os olhos eram elegíveis, o olho direito foi escolhido 
arbitrariamente para análise. 
Resultados: Foram incluídos 196 olhos de 196 pacientes (58,3 ± 11,6 anos) que 
foram submetidos à LPI. Na maioria dos casos [86% (169 pacientes; 133 mulheres 
e 36 homens), a LPI foi capaz de abrir o ângulo. A PIO média foi reduzida de 18,3 ± 
6,4 para 15,4 ± 4,5 mmHg após a LPI (p<0,01). Entre os 27 casos que persistiram com 
ângulo oclusível, os mecanismos mais comuns envolvidos foram íris em platô (56%) 
e induzido por componente cristaliniano (34%). A maioria desses casos (85%) foram 
tratados com iridoplastia periférica a laser (ALPI). Aproximadamente 90% tornaram-se 
não oclusíveis após a ALPI (redução média da PIO de 18,9%), não havendo diferença 
significativa entre os pacientes com componentes de íris em platô ou cristaliniano 
(p=0,34; seguimento médio de 11,4 ± 3,6 meses). 
Conclusões: Nossos resultados sugerem que, nessa população de pacientes brasileiros, 
parte dos olhos com fechamento angular não foi completamente tratada com LPI. 
Nesta série de pacientes de meia-idade, a presença de íris em platô foi a principal causa 
de fechamento angular persistente, sendo efetivamente tratada com ALPI. Acreditamos 
que um exame gonioscópico detalhado deva ser realizado após a LPI para descartar 
fechamento angular persistente por outros mecanismos que não bloqueio pupilar.
Descritores: Fechamento angular; Bloqueio pupilar; Doenças da íris; Irís/patologia; 
Iridectomia; Resultado de tratamento
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for management of primary angle closure in Asian, North American, 
and European populations, there are scant data with regard to South 
American patients(2,11-16). In the present study, we investigated the 
prevalence and treatment outcomes of angle-closure mechanisms 
other than pupillary block in a population of Brazilian patients.
METHODs
Patients
After Institutional Review Board approval, a comprehensive chart 
review was conducted to evaluate consecutive patients who un-
derwent LPI due to occludable angles at a single institution between 
July 2009 and April 2012. An occludable angle was defined as an eye 
in which the posterior trabecular meshwork was not visible for ≥180° 
without indentation on dark-room gonioscopy. Because some eyes 
may not have irido-trabecular contact even when the trabecular 
meshwork is not visible, an additional requirement was that corneal 
and iris beams of light should merge during non-indentation gonios-
copy (in order to confirm the presence of irido-trabecular contact). 
Eyes with previous incisional surgery, with >90° of peripheral anterior 
synechiae (PAS), ocular trauma, uveitis, or any other form of seconda-
ry glaucoma were excluded. 
Data collection anD ProceDures
Data collected were age, gender, race, presence of glaucoma, 
pre- and post-laser intraocular pressure (IOP), number of antiglauco-
ma medications, angle status and underlying angle-closure mecha-
nisms as determined by gonioscopy and subsequent management 
during follow-up. All laser procedures, pre- and post-laser goniosco-
py assessments and IOP measurements were performed by two ex-
perienced glaucoma specialists (LGB and TSP). In all cases, dark-room 
gonioscopy was performed with and without indentation using a 
Posner four-mirror lens (Ocular Instruments Inc., Bellevue, WA, USA). 
The light beam was set at 1-2 mm to avoid illuminating the pupil, 
and the most posterior region of the anterior chamber angle that was 
visible without indentation was determined. The angle was classified 
as occludable or non-occludable based on the previously mentioned 
definition. Regarding ALPI parameters, a 500 micron spot, 500 ms 
duration and 250 mW power were routinely used, which could vary 
according to iris pigmentation and tissue response. The center of a 
Goldmann 3 mirror lens was used and, after the procedure, predniso-
lone acetate 1% was administered four times per day for one week. 
In brief, the main mechanisms of angle closure could be descri-
bed as follows: (1) relative pupillary block, which results from increa-
sed resistance to the flow of aqueous humor between the pupillary 
portion of the iris and the anterior lens surface; (2) plateau iris (Figure 
1 A), which results from an abnormal anatomical configuration/rela-
tionship of the anterior chamber angle and ciliary body and is usually 
confirmed after a LPI failure; and (3) lens induced (Figure 1 B), which 
involves a normal or large lens pushing the iris forward and resulting 
in a reduced anterior chamber volume and angle-closure(4-7). 
On indentation gonioscopy, eyes with a relatively deep central 
anterior chamber and irido-trabecular contact after LPI in which the 
“double hump sign” was identified were considered to exhibit plateau 
iris component. On the other hand, those with a shallower central 
anterior chamber in which the iris appeared to drape the anterior 
surface of the lens, giving rise to a “volcano-like” configuration were 
considered to exhibit the lens-induced component(5,8). Ultrasound 
biomicroscopy was used in most cases of persistent occludable 
angles following LPI. 
statistical analysis 
Descriptive analysis was used to present demographic and cli-
nical data. D’Agostino-Pearson’s test was performed to determine 
whether the data had a normal distribution. The paired-samples T-test 
was used to compare continuous normally distributed variables, 
while the Wilcoxon signed-rank test was used to compare those that 
were non-normally distributed. Baseline IOP was determined as the 
average of three measurements prior to the laser procedures. Post-laser 
IOP was based on a single measurement (IOP measurement on each 
patient’s last visit). The treatment regimen was not altered until the 
final follow-up visit. If both eyes were eligible for inclusion, the right 
eye was arbitrarily chosen for analysis. Statistical significance was 
set at p<0.05. Computerized analysis was performed using MedCalc 
software (MedCalc Inc., Mariakerke, Belgium).
REsULTs
A total of 196 eyes of 196 consecutive patients (mean age 58.3 
± 11.6 years; 133 women and 36 men) who underwent LPI were 
included. Primary angle-closure suspects/primary angle closure 
constituted 54% of the cases, primary angle-closure glaucoma 40% 
and acute angle-closure glaucoma 6%. In most of the cases (86%), LPI 
successfully opened the angle. Mean IOP was reduced from 18.3 ± 6.4 
to 15.4 ± 4.5 mmHg after LPI (p<0.01). 
Forty-one eyes (27 patients) had persistent occludable angles 
after LPI, comprising approximately 14% of the cases that had pre-
viously undergone iridotomy. Among these cases, the most common 
angle-closure mechanisms were plateau iris (56%) and lens-induced 
component (34%). Regarding the remaining 10% of the cases of 
persistent occludable angles (without characteristics of plateau iris or 
lens-induced component), most eyes had a thick peripheral iris with 
prominent circumferential folds, occupying a large proportion of the 
angle, and were classified as thick peripheral iris roll (or peripheral 
iris crowding)(4,5). Patients with plateau iris were mostly women (75%) 
and younger (mean age 55.3 years) than those with lens-induced 
component (mean age 64.8 years; 30% women; p≤0.03). None of the 
patients were taking pilocarpine prior to the laser procedures. Table 1 
summarizes the clinical characteristics of these patients. 
Most of these cases of persistent occludable angles following LPI 
were treated with laser iridoplasty (85%). Regarding the four other 
patients, two had cataracts associated with low visual acuity and 
A b
Figure 1. Ultrasound biomicroscopy images of two patients with persistent occlu­
dable angles following laser peripheral iridotomy due to plateau iris (A) and lens­induced 
component (B).
Table 1. Characteristics of patients with persistent occludable angle 
due to non-pupillary mechanisms*
Variables Patients (n=27)
Mean age (years) 58.9 ± 11.8
Gender % (men/women) 44/56
Race % (white/black/asian) 78/15/7
Presence of glaucoma (%) 63% 
Angle-closure mechanisms % (PIC/LIAC/others) 56/34/10
Mean IOP before ALPI (mmHg) 17.9 ± 4.9
Mean IOP after ALPI (mmHg) 14.5 ± 4.2
*Data are presented as mean ± standard deviation whenever indicated.
ALPI= argon laser peripheral iridoplasty; IOP= intraocular pressure; LIAC= lens-induced 
angle closure; PIC= plateau iris component.
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underwent phacoemulsification with intraocular lens implantation, 
and two were treated with pilocarpine at night-time. Treatment regi-
mens were not changed until the final follow-up visit (mean length 
of follow-up, 11.4 ± 3.6 months; mean number of antiglaucoma 
medications, 1.7 ± 1.3). Approximately 90% of the cases showed 
non-occludable angles following ALPI. Intraocular pressure was sig -
nificantly reduced from 17.9 ± 4.9 to 14.5 ± 4.2 (p<0.01) with no 
sig nificant differences between patients with plateau iris and lens-in-
duced components (p=0.34). Although some cases of photophobia 
were noted, there were no cases of peripheral anterior synechiae 
formation. 
DIsCUssION
Recent estimates show that >67 million individuals around the 
world have glaucoma. Although open-angle glaucoma comprises 
approximately two-thirds of these cases, angle-closure glaucoma is 
present in one-half of patients who are blind from the disease(17,18). 
In addition, in populations such as Chinese, Indian and Mongolian, 
the prevalence of angle-closure glaucoma is as high or even higher 
than that of open-angle glaucoma(16,17,19-22). Therefore, angle-closure 
glaucoma has a considerable impact on daily clinical practice. Evalua-
ting a large series of patients with primary angle closure (with and 
without glaucoma), we determined the most frequent underlying 
angle-closure mechanisms and the outcomes of laser treatment 
(both iridotomy and iridoplasty). To the best of our knowledge, the 
present study is the first to report on such findings in a large sample 
of Brazilian patients. 
At this point, we believe it is important to discuss the clinical im-
plications of our findings. Treatment of primary angle-closure is 
directed toward two goals: to eliminate the mechanism of angle 
closure and to control IOP elevation(14). Previous studies have shown 
that following LPI, approximately 20%-30% of these patients conti-
nue to exhibit appositional angle closure in the presence of a patent 
iridotomy(1-3). In our study, we found a slightly higher success rate, 
as 86% of the eyes showed non-occludable angles following LPI. 
Although these differences may be the result of a lower prevalence of 
non-pupillary block mechanisms in our study population, we believe 
that age (the mean age of our study population was <60 years and, 
thus, the prevalence of lens-induced component was likely low) and 
the fact we excluded patients with >90° of PAS should be taken into 
consideration. 
Although laser iridotomy is currently the first line of treatment, 
many eyes will continue to exhibit appositional angle-closure, and 
an additional treatment option may be necessary(2,3). In the present 
large consecutive series, ALPI was highly effective in eliminating re-
sidual appositional angle closure caused by mechanisms other than 
pupillary block. In addition, we documented a 20% IOP reduction 
on average. Our results not only confirm the important role of ALPI 
in cases of plateau iris(8), but also suggest that it may be an effective 
alternative in cases involving lens-induced component. We believe 
that this is clinically meaningful, as not every case of lens-induced 
angle closure necessarily coexists with a symptomatic cataract. In fact, 
this appears to be the case of our study population, which is mostly 
composed of middle-aged patients. It is noteworthy that ALPI has 
also been successfully used as an initial treatment to break acute 
phacomorphic attacks(23). Regarding the few cases in which ALPI was 
not effective in our series, the proportion was similar between eyes 
with plateau iris and lens-induced component, and we could not 
identify any predictors of success or failure. As additional findings, our 
plateau iris patients tended to be women and younger than those 
with lens-induced component, and ALPI effectiveness was similar in 
both angle-closure mechanisms during an average follow-up period 
of almost one year. 
We believe it is important to stress some specific characteristics 
and limitations of our study. First, our study is based on retrospective 
data and had a relative short follow-up period. Therefore, success ra-
tes, especially related to ALPI, may have been positively influenced. 
Second, a subjective gonioscopic criterion was adopted for each 
angle-closure mechanism. Moreover, ultrasound biomicroscopy 
images were available for most patients with persistent occludable 
angles following LPI, but not for every patient. These missing ultra-
sound biomicroscopy data could have added useful information 
(such as anterior chamber depth measurements) to our results. Third, 
ideally, different examiners should have performed pre- and post-laser 
gonioscopic examinations. However, the present study was retros-
pective, and each glaucoma specialist performed not only the laser 
procedure, but also baseline and post-laser gonioscopy assessments. 
This potential bias of data collection should be considered while in-
terpreting our results. Fourth, although Brazil is a multiracial country, 
our patients were enrolled from just one center (in the city of Osasco, 
São Paulo). Therefore, our results may not be representative of the en-
tire Brazilian population. However, it should be emphasized that São 
Paulo has a high rate of immigration and, as a result, its population is 
composed of individuals from all over the country. 
In conclusion, our findings suggest that, in this population of Bra-
zilian patients, several eyes with angle closure were not completely 
treated with LPI. In the present large series of middle-aged patients, 
plateau iris was the leading cause of persistent angle closure and 
was effectively treated with ALPI. A detailed eye examination with 
indentation gonioscopy should always be performed after LPI to rule 
out persistent angle closure due to non-pupillary block mechanisms.
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